Bill Text: HI HB431 | 2024 | Regular Session | Introduced


Bill Title: Relating To Drug Paraphernalia.

Spectrum: Partisan Bill (Democrat 12-0)

Status: (Introduced) 2023-12-11 - Carried over to 2024 Regular Session. [HB431 Detail]

Download: Hawaii-2024-HB431-Introduced.html

HOUSE OF REPRESENTATIVES

H.B. NO.

431

THIRTY-SECOND LEGISLATURE, 2023

 

STATE OF HAWAII

 

 

 

 

 

 

A BILL FOR AN ACT

 

 

relating to DRUG PARAPHERNALIA.

 

 

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

 


     SECTION 1.  The legislature finds that law enforcement across the State has confiscated fentanyl test strips among registered participants in Hawaii's statewide syringe exchange program, thereby increasing the risk of accidental overdose or fatal overdose.  Although fentanyl test strip distribution is an established feature of Hawaii's statewide syringe exchange program and its ongoing overdose prevention efforts, some argue that fentanyl test strips are not exempt from the State's existing paraphernalia law.

     The legislature further finds that, for over three decades, Hawaii's statewide syringe exchange program has effectively prevented the transmission of the human immunodeficiency virus, also referred to as HIV, among persons who inject drugs.  The program also provides needed outreach and linkage services to improve the health and well-being of those from the State's under-resourced and medically vulnerable populations, including those on the neighbor islands.

     Drug law enforcement in the State, like the larger criminal legal system, continues to disproportionately impact Native Hawaiian residents and families.  Under-resourced persons, including those who are unhoused, are also subject to disproportionate involvement in the criminal legal system across the State.

     According to a December 2020 report from The Pew Charitable Trusts, Hawaii has the longest average term of probation in the United States at fifty-nine months.  That is well over twice the national average of just under two years and six times the average term of Kansas, the state with the shortest average probation term.

     The American Public Health Association recognizes in its policy statement "Defining and Implementing a Public Health Response to Drug Use and Misuse" that "the current 'war on drugs' is a 'severely flawed' approach based on 'misplaced priorities and strategies'".  The American Public Health Association notes that "the domestic drug war has also been an engine of mass incarceration".  Further, "criminalization of substance use further stigmatizes people who use drugs, making it more difficult to engage people in health care and other services".  As such, the American Public Health Association calls for a full policy reorientation that includes ending the criminalization of drug possession and people who use drugs.

     An October 2022 article in the New England Journal of Medicine called for the federal government to encourage states to repeal their paraphernalia laws entirely, noting that these laws were calling them harmful and unnecessary, and reduced access to safer use supplies.  Furthermore, the article noted how the enforcement of paraphernalia laws falls disproportionately on people of color and members of other marginalized groups and called upon the federal government to take an active role in shifting the country's legal environment from "one that stigmatizes and criminalizes people who use drugs to one that prioritizes their agency, dignity, and health".

     Although possession of syringes obtained through the Hawaii's statewide syringe exchange program are exempt from criminal charges under Hawaii's existing paraphernalia law, the mere presence of any amount of a drug like heroin or amphetamines, including unusable traces and residue, in a syringe can be charged as a class C felony that carries a penalty of up to five years in prison.

     Accordingly, the purpose of this Act is to repeal the prohibited acts related to drug paraphernalia under the uniform controlled substances act, which will:

     (1)  Help ensure the efficacy of Hawaii's ongoing public health efforts to prevent accidental overdoses, fatal overdoses, and the transmission of the human immunodeficiency virus and hepatitis C;

     (2)  Facilitate the expansion of harm reduction-based public health interventions among under resourced persons; and

     (3)  Reduce the involvement of persons with behavioral health problems in the State's criminal legal system.

     SECTION 2.  Section 325-21, Hawaii Revised Statutes, is amended to read as follows:

     "[[]§325-21[]]  Sale of sterile syringes for the prevention of disease.  (a)  The sale of sterile hypodermic syringes in a pharmacy, physician's office, or health care institution for the purpose of preventing the transmission of dangerous blood-borne diseases, may be made solely by:

     (1)  A pharmacist licensed under chapter 461;

     (2)  A physician as defined in section 327E-2;

     (3)  A health care provider as defined in section 327E-2; or

     (4)  An authorized agent of a pharmacy, as defined in section 461-1, or of a health care institution, as defined in section 327E-2, operating under the direction of a licensed pharmacist or physician.

     (b)  The seller under subsection (a) shall provide the purchaser written educational material approved by the department of health under subsection [(e)] (d) about prevention of blood-borne diseases, drug treatment, and safe disposal of used syringes at sites where syringes are sold.

     [(c)  The sale or purchase of sterile hypodermic syringes under subsection (a) shall not constitute an offense under section 329-43.5.

     (d)] (c)  Nothing in this section provides immunity from prosecution to any person who violates any law that prohibits or regulates the use, possession, dispensing, distribution, or promotion of controlled substances, dangerous drugs, detrimental drugs, or harmful drugs, including but not limited to violation of section 329-41, 329-42, or 712-1241 to 712-1249.6.

     [(e)] (d)  The department of health shall produce and make available to pharmacies, physicians' offices, and health care institutions written educational material about prevention of blood-borne diseases, drug treatment, and safe disposal of used syringes for distribution under subsection (b).

     [(f)] (e)  For purposes of this section, "sell" or "sale" means to transfer to another for value or consideration."

     SECTION 3.  Section 325-114, Hawaii Revised Statutes, is amended to read as follows:

     "[[]§325-114[]]  Criminal liability.  [(a)  Exchanges under the sterile needle and syringe exchange program shall not constitute an offense under section 329-43.5 for the participant or for the employees of the department or its designees.

     (b)]  Nothing in this part provides immunity from prosecution to any person for violation of any law prohibiting or regulating the use, possession, dispensing, distribution, or promotion of controlled substances, dangerous drugs, detrimental drugs, or harmful drugs.  Nothing in this part provides immunity from prosecution to any person for violation of sections 329-41, 329-42, or 712-1241 through 712-1249.6."

     SECTION 4.  Section 329-55, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

     "(a)  The following are subject to forfeiture according to the procedures set forth in the Penal Code:

     (1)  All controlled substances and anabolic steroids which have been manufactured, cultivated, grown, distributed, dispensed, or acquired in violation of this chapter;

     (2)  All raw materials, products, and equipment of any kind which are used, or intended for use, in manufacturing, cultivating, growing, compounding, processing, delivering, importing, or exporting any controlled substance or anabolic steroid in violation of this chapter;

     (3)  All property which is used, or intended for use, as a container for property described in paragraph (1) or (2);

     (4)  All conveyances, including aircraft, vehicles, or vessels which are used or intended for use, to transport, or in any manner to facilitate the transportation, for the purpose of sale, delivery or receipt of property described in paragraph (1) or (2), subject to the provisions of chapter 712A;

     (5)  All books, records, and research products and materials, including formulas, microfilms, tapes, and data which are used, or intended for use, in violation of this chapter;

     (6)  All moneys, negotiable instruments, securities, or other things of value furnished or intended to be furnished by any person in exchange for a controlled substance or anabolic steroid in violation of this chapter, all proceeds traceable to such an exchange, and all moneys, negotiable instruments, and securities used or intended to be used to facilitate any violation of this chapter, subject to the provisions of chapter 712A; and

     (7)  All firearms which are visible, carried during, or used in furtherance of a violation of this chapter or chapter 712, part IV[; and

     (8)  All drug paraphernalia as defined by section 329-1]."

     SECTION 5.  Section 353-66, Hawaii Revised Statutes, is amended by amending subsection (f) to read as follows:

     "(f)  The Hawaii paroling authority may require a paroled prisoner to undergo and complete a substance abuse treatment program when the paroled prisoner has committed a violation of the terms and conditions of parole involving possession or use, not including to distribute or manufacture as defined in section 712-1240, of any dangerous drug, detrimental drug, harmful drug, intoxicating compound, marijuana, or marijuana concentrate, as defined in section 712-1240, or unlawful methamphetamine trafficking as provided in section 712-1240.6[, or involving possession or use of drug paraphernalia under section 329-43.5].  If the paroled prisoner fails to complete the substance abuse treatment program or the Hawaii paroling authority determines that the paroled prisoner cannot benefit from any substance abuse treatment program, the paroled prisoner shall be subject to revocation of parole and return to incarceration.  As a condition of parole, the Hawaii paroling authority may require the paroled prisoner to:

     (1)  Be assessed by a certified substance abuse counselor for substance abuse dependency or abuse under the applicable Diagnostic and Statistical Manual and Addiction Severity Index;

     (2)  Present a proposal to receive substance abuse treatment in accordance with the treatment plan prepared by a certified substance abuse counselor through a substance abuse treatment program that includes an identified source of payment for the treatment program;

     (3)  Contribute to the cost of the substance abuse treatment program; and

     (4)  Comply with any other terms and conditions for parole.

     As used in this subsection, "substance abuse treatment program" means drug or substance abuse treatment services provided outside a correctional facility by a public, private, or nonprofit entity that specializes in treating persons who are diagnosed with having substance abuse or dependency and preferably employs licensed professionals or certified substance abuse counselors.

     Nothing in this subsection shall be construed to give rise to a cause of action against the State, a state employee, or a treatment provider."

     SECTION 6.  Section 706-622.5, Hawaii Revised Statutes, is amended by amending subsection (1) to read as follows:

     "(1)  Notwithstanding section 706-620(3), a person convicted for the first or second time for [any offense under section 329-43.5, except offenses under subsections (a) and (b) of that section which constitute violations, involving the possession or use of drug paraphernalia or] any felony offense under part IV of chapter 712 involving the possession or use of any dangerous drug, detrimental drug, harmful drug, intoxicating compound, marijuana, or marijuana concentrate, as defined in section 712‑1240, but not including any offense under part IV of chapter 712 involving the distribution or manufacture of any such drugs or substances and not including any methamphetamine offenses under sections 712‑1240.7, 712‑1240.8 as that section was in effect before July 1, 2016, 712-1241, and 712-1242, is eligible to be sentenced to probation under subsection (2) if the person meets the following criteria:

     (a)  The court has determined that the person is nonviolent after reviewing the person's criminal history, the factual circumstances of the offense for which the person is being sentenced, and any other relevant information;

     (b)  The person has been assessed by a certified substance abuse counselor to be in need of substance abuse treatment due to dependency or abuse under the applicable Diagnostic and Statistical Manual and Addiction Severity Index; and

     (c)  Except for those persons directed to substance abuse treatment under the supervision of the drug court, the person presents a proposal to receive substance abuse treatment in accordance with the treatment plan prepared by a certified substance abuse counselor through a substance abuse treatment program that includes an identified source of payment for the treatment program."

     SECTION 7.  Section 706-625, Hawaii Revised Statutes, is amended by amending subsection (7) to read as follows:

     "(7)  The court may require a defendant to undergo and complete a substance abuse treatment program when the defendant has committed a violation of the terms and conditions of probation involving possession or use, not including to distribute or manufacture as defined in section 712-1240, of any dangerous drug, detrimental drug, harmful drug, intoxicating compound, marijuana, or marijuana concentrate, as defined in section 712-1240, or unlawful methamphetamine trafficking as provided in section 712-1240.6[, or involving possession or use of drug paraphernalia under section 329-43.5].  If the defendant fails to complete the substance abuse treatment program or the court determines that the defendant cannot benefit from any other suitable substance abuse treatment program, the defendant shall be subject to revocation of probation and incarceration.  The court may require the defendant to:

     (a)  Be assessed by a certified substance abuse counselor for substance abuse dependency or abuse under the applicable Diagnostic and Statistical Manual and Addiction Severity Index;

     (b)  Present a proposal to receive substance abuse treatment in accordance with the treatment plan prepared by a certified substance abuse counselor through a substance abuse treatment program that includes an identified source of payment for the treatment program;

     (c)  Contribute to the cost of the substance abuse treatment program; and

     (d)  Comply with any other terms and conditions of probation.

     As used in this subsection, "substance abuse treatment program" means drug or substance abuse treatment services provided outside a correctional facility by a public, private, or nonprofit entity that specializes in treating persons who are diagnosed with substance abuse or dependency and preferably employs licensed professionals or certified substance abuse counselors.

     Nothing in this subsection shall be construed to give rise to a cause of action against the State, a state employee, or a treatment provider."

     SECTION 8.  Section 329-43.5, Hawaii Revised Statutes, is repealed.

     ["§329-43.5  Prohibited acts related to drug paraphernalia.  (a)  Except as provided in subsection (e), it is unlawful for any person to use, or to possess with intent to use, drug paraphernalia to plant, propagate, cultivate, grow, harvest, manufacture, compound, convert, produce, process, prepare, test, analyze, pack, repack, store, contain, conceal, inject, ingest, inhale, or otherwise introduce into the human body a controlled substance in violation of this chapter.  A violation of this subsection shall constitute a violation subject to a fine of no more than $500.

     (b)  Except as provided in subsection (e), it is unlawful for any person to deliver, possess with intent to deliver, or manufacture with intent to deliver drug paraphernalia, knowing or under circumstances where one reasonably should know, that it will be used to plant, propagate, cultivate, grow, harvest, manufacture, compound, convert, produce, process, prepare, test, analyze, pack, repack, store, contain, conceal, inject, ingest, inhale, or otherwise introduce into the human body a controlled substance in violation of this chapter.  A violation of this subsection shall constitute a violation subject to a fine of no more than $500.

     (c)  Any person eighteen years of age or over who violates subsection (b) by delivering drug paraphernalia to a person or persons under eighteen years of age who are at least three years younger than that adult person is guilty of a class B felony and upon conviction may be imprisoned pursuant to section 706-660 and, if appropriate as provided in section 706-641, fined pursuant to section 706-640.

     (d)  It is unlawful for any person to place in any newspaper, magazine, handbill, or other publication any advertisement, knowing or under circumstances where one reasonably should know, that the purpose of the advertisement, in whole or in part, is to promote the sale of objects designed or intended for use as drug paraphernalia.  Any person who violates this section is guilty of a class C felony and upon conviction may be imprisoned pursuant to section 706-660 and, if appropriate as provided in section 706-641, fined pursuant to section 706-640.

     (e)  Subsections (a) and (b) shall not apply to a person who is authorized to:

     (1)  Acquire, possess, cultivate, use, distribute, or transport cannabis pursuant to the definition of "medical use" under section 329-121, while the person is facilitating the medical use of cannabis by a qualifying patient; or

     (2)  Dispense, manufacture, or produce cannabis or manufactured cannabis products pursuant to and in compliance with chapter 329D, while the person is facilitating the medical use of cannabis by a qualifying patient pursuant to part IX of chapter 329."]

     SECTION 9.  Statutory material to be repealed is bracketed and stricken.  New statutory material is underscored.

     SECTION 10.  This Act shall take effect upon its approval.

 

INTRODUCED BY:

_____________________________

 

 


 


 

Report Title:

Uniform Controlled Substances Act; Drug Paraphernalia

 

Description:

Repeals the prohibited acts related to drug paraphernalia under the uniform controlled substances act.

 

 

 

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.

feedback